Key points are not available for this paper at this time.
Design
Editorial
The author emphasizes that surgical innovation outcomes must be evaluated using metrics beyond what can be tested in randomized controlled trials.
The process of innovation is always valuable and can lead to great advances, both intended and unanticipated. However, the outcomes must always be carefully examined in terms of metric which considers more than could ever be tested in a RCT.
No takes yet. Share an insight, caveat, or question.
Khoma et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: